Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2017 Jan 1;97(1):164-172.
doi: 10.1016/j.ijrobp.2016.10.005. Epub 2016 Oct 13.

Highly Efficient Training, Refinement, and Validation of a Knowledge-based Planning Quality-Control System for Radiation Therapy Clinical Trials

Affiliations
Multicenter Study

Highly Efficient Training, Refinement, and Validation of a Knowledge-based Planning Quality-Control System for Radiation Therapy Clinical Trials

Nan Li et al. Int J Radiat Oncol Biol Phys. .

Abstract

Purpose: To demonstrate an efficient method for training and validation of a knowledge-based planning (KBP) system as a radiation therapy clinical trial plan quality-control system.

Methods and materials: We analyzed 86 patients with stage IB through IVA cervical cancer treated with intensity modulated radiation therapy at 2 institutions according to the standards of the INTERTECC (International Evaluation of Radiotherapy Technology Effectiveness in Cervical Cancer, National Clinical Trials Network identifier: 01554397) protocol. The protocol used a planning target volume and 2 primary organs at risk: pelvic bone marrow (PBM) and bowel. Secondary organs at risk were rectum and bladder. Initial unfiltered dose-volume histogram (DVH) estimation models were trained using all 86 plans. Refined training sets were created by removing sub-optimal plans from the unfiltered sample, and DVH estimation models… and DVH estimation models were constructed by identifying 30 of 86 plans emphasizing PBM sparing (comparing protocol-specified dosimetric cutpoints V10 (percentage volume of PBM receiving at least 10 Gy dose) and V20 (percentage volume of PBM receiving at least 20 Gy dose) with unfiltered predictions) and another 30 of 86 plans emphasizing bowel sparing (comparing V40 (absolute volume of bowel receiving at least 40 Gy dose) and V45 (absolute volume of bowel receiving at least 45 Gy dose), 9 in common with the PBM set). To obtain deliverable KBP plans, refined models must inform patient-specific optimization objectives and/or priorities (an auto-planning "routine"). Four candidate routines emphasizing different tradeoffs were composed, and a script was developed to automatically re-plan multiple patients with each routine. After selection of the routine that best met protocol objectives in the 51-patient training sample (KBPFINAL), protocol-specific DVH metrics and normal tissue complication probability were compared for original versus KBPFINAL plans across the 35-patient validation set. Paired t tests were used to test differences between planning sets.

Results: KBPFINAL plans outperformed manual planning across the validation set in all protocol-specific DVH cutpoints. The mean normal tissue complication probability for gastrointestinal toxicity was lower for KBPFINAL versus validation-set plans (48.7% vs 53.8%, P<.001). Similarly, the estimated mean white blood cell count nadir was higher (2.77 vs 2.49 k/mL, P<.001) with KBPFINAL plans, indicating lowered probability of hematologic toxicity.

Conclusions: This work demonstrates that a KBP system can be efficiently trained and refined for use in radiation therapy clinical trials with minimal effort. This patient-specific plan quality control resulted in improvements on protocol-specific dosimetric endpoints.

PubMed Disclaimer

Conflict of interest statement

Dr. Bosch reports personal fees from Augmenix, Inc., other from ASTRO, other from AAPM, outside the submitted work; Dr. Straube reports grants from National Institutes of Health, during the conduct of the study; Dr. Mell reports grants from U.S National Institutes of Health, grants and personal fees from Varian Medical System, during the conduct of the study; Dr. Moore reports grants from National Institute of Health, grants, personal fees and non-financial support from Varian Medical Systems, during the conduct of the study; In addition, Dr. Moore has a patent US Patent 20,120,310,615 licensed to Varian Medical Systems, and a patent THREE-DIMENSIONAL RADIOTHERAPY DOSE DISTRIBUTION PREDICTION pending.

Figures

Figure 1
Figure 1
Flow Diagram of this study.
Figure 2
Figure 2
Comparison of average DVHs of the original and KBPFINAL plans for 35 validation patients. a). Average DVH comparison. PTV, planning target volume; PBM, pelvic bone marrow. b). Difference of average DVH between original and KBPFINAL. Note that the regions of improvement are in the protocol-specified 10–20 Gy region of the PBM DVH and in the high dose region >40 Gy region of the bowel DVH.
Figure 3
Figure 3
Comparison of the PBM and Bowel DVH metrics between original and KBPFINAL in the training and validation sets. PBM a) V10 and b) V20 comparison between original plan and KBPFINAL for each patient. Bowel c) V40 and d) V45 comparison between original plan and KBPFINAL for each patient.
Figure 4
Figure 4
Frequency histogram of the difference of NTCP and estimated WBC nadir between original and KBPFINAL plans across the training set (grey) and validation set (white).

References

    1. Nelms BE, Robinson G, Markham J, et al. Variation in external beam treatment plan quality: An inter-institutional study of planners and planning systems. Pract Radiat Oncol. 2012;2:296–305. - PubMed
    1. Das IJ, Cheng CW, Chopra KL, et al. Intensity-modulated radiation therapy dose prescription, recording, and delivery: Patterns of variability among institutions and treatment planning systems. J natl cancer inst United States. 2008:300–7. - PubMed
    1. Appenzoller LM, Michalski JM, Thorstad WL, et al. Predicting dose-volume histograms for organs-at-risk in imrt planning. Med Phys. 2012;39:7446–61. - PubMed
    1. Moore KL, Mutic S, Brame RS, et al. Developing predictive dose-volume relationships for a radiotherapy treatment. Book Developing predictive dose-volume relationships for a radiotherapy treatment: Google Patents. 2012 Editor, editorˆeditors.
    1. Moore KL, Brame RS, Low DA, et al. Quantitative metrics for assessing plan quality. Seminars in radiation oncology. 2012;22:62–69. - PubMed

MeSH terms